Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cruickshank

Showing results (121-130 of 343) with videos related to

Pageof 35
Sort By:
Journal of Rehabilitation|April 1, 1984
Definition: a major issue in the field of learning disabilitiesW M Cruickshank
Journal of Cardiovascular Pharmacology|January 1, 1992
Beta-blockers: primary and secondary preventionJ M Cruickshank
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|June 1, 1992
The case for beta-blockers as first-line antihypertensive therapyJ M Cruickshank
Blood Pressure. Supplement|January 1, 1992
Reversibility of left ventricular hypertrophyJ M Cruickshank
American Heart Journal|August 1, 1980
The clinical importance of cardioselectivity and lipophilicity in beta blockersJ M Cruickshank
Science (New York, N.Y.)|November 2, 1973
Gordon research conferences, winter program, 1974A M Cruickshank
Science (New York, N.Y.)|October 22, 1976
Gordon research conferences: winter program, 1977A M Cruickshank
Science (New York, N.Y.)|November 2, 1979
Gordon research conferencesA M Cruickshank
Science (New York, N.Y.)|March 14, 1975
Gordon research conferencesA M Cruickshank
Science (New York, N.Y.)|March 8, 1974
Gordon research conferencesA M Cruickshank
Pageof 35

Showing results (121-130 of 343) with videos related to

Sort By:
Pageof 35
Journal of Rehabilitation|April 1, 1984
Definition: a major issue in the field of learning disabilitiesW M Cruickshank
Journal of Cardiovascular Pharmacology|January 1, 1992
Beta-blockers: primary and secondary preventionJ M Cruickshank
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|June 1, 1992
The case for beta-blockers as first-line antihypertensive therapyJ M Cruickshank
Blood Pressure. Supplement|January 1, 1992
Reversibility of left ventricular hypertrophyJ M Cruickshank
American Heart Journal|August 1, 1980
The clinical importance of cardioselectivity and lipophilicity in beta blockersJ M Cruickshank
Science (New York, N.Y.)|November 2, 1973
Gordon research conferences, winter program, 1974A M Cruickshank
Science (New York, N.Y.)|October 22, 1976
Gordon research conferences: winter program, 1977A M Cruickshank
Science (New York, N.Y.)|November 2, 1979
Gordon research conferencesA M Cruickshank
Science (New York, N.Y.)|March 14, 1975
Gordon research conferencesA M Cruickshank
Science (New York, N.Y.)|March 8, 1974
Gordon research conferencesA M Cruickshank
Pageof 35